tiprankstipranks
Oculis Holding (OCS)
NASDAQ:OCS

Oculis Holding (OCS) Similar Stocks

Compare
58 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Oculis Holding
$19.03
$920.64M
63.77%
5 Buy
0 Hold
0 Sell
Strong Buy
Blueprint Medicines
$88.51
$5.67B
-8.20%
14 Buy
4 Hold
0 Sell
Strong Buy
Editas Medicine
$1.16
$103.72M
-84.07%
3 Buy
5 Hold
1 Sell
Hold
Intellia Therapeutics
$7.11
$835.39M
-73.88%
15 Buy
4 Hold
1 Sell
Moderate Buy
Crispr Therapeutics AG
$34.03
$3.17B
-50.09%
12 Buy
7 Hold
1 Sell
Moderate Buy
Arvinas Holding Company
$7.02
$521.98M
-82.88%
12 Buy
5 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
OCS
Oculis Holding
19.03
7.41
63.77%
BPMC
Blueprint Medicines
88.51
-7.91
-8.20%
EDIT
Editas Medicine
1.16
-6.12
-84.07%
NTLA
Intellia Therapeutics
7.11
-20.11
-73.88%
CRSP
Crispr Therapeutics AG
34.03
-34.15
-50.09%
ARVN
Arvinas Holding Company
7.02
-33.38
-82.62%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis